Skip to search formSkip to main contentSkip to account menu

CCR9 protein, human

Known as: chemokine (C-C motif) receptor 9 protein, human, C-C Chemokine Receptor Type 9, CCR9 
C-C chemokine receptor type 9 (369 aa, ~42 kDa) is encoded by the human CCR9 gene. This protein is involved in chemokine-dependent G protein-coupled… 
National Institutes of Health

Related topics

Related topics

25 relations
ACKR2 geneCCBP2 protein, humanCCR9 geneCCR9 wt Allele

Broader (1)

CC chemokine receptor 9

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Correction: Repression of Ccr9 Transcription in Mouse T Lymphocyte Progenitors by the Notch Signaling Pathway
Krishnamoorthy, V., T. Carr, R. F. de Pooter, E. O. Akinola, F. Gounari, and B. L. Kee. 2015. Repression of Ccr9 transcription in… 
2015
2015
IMMUNOLOGICAL MECHANISMS UNDERLYING INFLAMMATORY BOWEL DISEASE
Ulcerative colitis (UC) and Crohn‘s disease (CD), collectively referred to as inflammatory bowel diseases (IBD), are… 
2015
2015
CCR 9 antagonism : potential in the treatment of Inflammatory Bowel Disease
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of… 
2010
2010
Abstract 5458: Clinical and biological significance of CCR9-CCL25 axis in prostate cancer
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Bone metastasis is major cause of prostate cancer… 
2009
2009
Mouse chromosome 9
The structure of the Chromosome 9 Committee Report (CCR9) has been changed to a large extent since the last publication of CCR9… 
2008
2008
1-benzenesulfonyl-1H-indole derivatives as inhibitors of CCR9 activity
1 -Benzenesulfonyl-I H-indoles, processes for their production and their use as pharmaceuticals, e.g. in the treatment of… 
2004
2004
Expression and Functional Role of CCR 9 in Prostate Cancer Cell Migration and Invasion
Purpose: Metastasis is responsible for most cancerrelated deaths; hence, therapies designed to minimize metastasis are greatly… 
2004
2004
Phenylenediamine urotensin -ii receptor antagonist and ccr-9 antagonists
The present invention, urotensin -II receptor antagonist, CCR-9 antagonists, these pharmaceutical compositions containing and to… 
2000
2000
CCR9 is a receptor for CCL25 with two forms that show differing sensitivities to ligand and that has SIV co-receptor
1999
1999
Cutting Edge: Identification of the Orphan Chemokine Receptor GPR-9-6 as CCR9, the Receptor for the